New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
BioVie Inc. (BIVI) vs TScan Therapeutics, Inc. (TCRX)
- BioVie Inc. BIVI 0.80 −12.09%
- TScan Therapeutics, Inc. TCRX 0.15 +7.14%
BioVie Inc. and TScan Therapeutics, Inc. are both Biotechnology companies. BioVie Inc. and TScan Therapeutics, Inc. are of similar size ($9.8M and $9.4M). BioVie Inc. has the higher net margin (0.00% vs −2,219.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, BioVie Inc. leads on 10 and TScan Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | BIVI | TCRX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | 0.00% | (2,246.84%) | 0.00% |
| Net margin | 0.00% | (2,219.19%) | 0.00% |
| Free cash flow margin | 0.00% | (2,152.72%) | 0.00% |
| Return on equity | (143.66%) | (126.45%) | (51.58%) |
| Return on assets | (119.34%) | (57.03%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack